Biotechnology News

November 5, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--athenahealth, Inc. (NASDAQ: ATHN), a leading provider of cloud-based practice management, electronic health record (EHR), and care coordination services to medical groups and health systems, today announced...

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Selventa to present at BIO-Europe 2012, and participate in panel on companion diagnostics.

November 5, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist has been named one of the Top Places to Work in Massachusetts in an annual employee-based survey from The Boston Globe. Cubist has been named to the list for five consecutive years.

November 5, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) today announced that it has received a Notice of Allowance of a U.S. patent for the use of Thymosin beta 4 (Tβ4), certain...

November 5, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer announced the launch of a panel of nine new epigenetic research assay kits for the detection of endogenous histone modifications.

November 5, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets...

November 5, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (OTCBB: APPA.OB), a specialty pharmaceutical company, today reported financial results for the quarter ended September 30, 2012 and highlighted recent corporate progress.

November 5, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Core research facilities on the Science Exchange network announced today their support for those researchers affected by Hurricane Sandy.

November 5, 2012

TARRYTOWN, N.Y.--(BUSINESS WIRE)--PsychoGenics today announced that the Food and Drug Administration (FDA) has accepted Sunovion’s IND for SEP360, triggering a milestone payment to PsychoGenics, and that human dosing has been initiated. In August...

November 5, 2012

NEW YORK--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO) announced that Eileen Schloss, a human resources and business administration executive with more than 25 years of experience and executive leadership, has been named executive vice...

November 5, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the Jefferies 2012 Global Healthcare Conference on Thursday, November 15 at 3:00 p.m. (GMT) / 10:00 a.m. (EST) in London. The presentation will...

November 5, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--FDA designated Durata Therapeutics' dalbavancin as a QIDP, conferring priority review, eligibility for fast-track status, & 5 years additional statutory exclusivity following FDA approval for ABSSSI.

November 5, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks has been fully National Center for Quality Assurance (NCQA) certified as a CAHPS® Patient-Centered Medical Home (PCMH) Survey Vendor to conduct NCQA HEDIS® Surveys.

November 5, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics announces upcoming data presentations at the Society of Neuro-Oncology’s 17th Annual Scientific Meeting and Education Day on Thursday, November 15, 2012.

November 5, 2012

BEVERLY, Mass.--(BUSINESS WIRE)--Genome Trax -- variant analysis tool assists in whole genome interpretation of next generation sequencing variants.

November 5, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that it will release its unaudited financial results for the quarter ended September 30, 2012 on Wednesday, November...

November 5, 2012

SAN DIEGO--(BUSINESS WIRE)--Santarus (SNTS) will be presenting at upcoming investor conferences in NYC on November 13 (9 am ET) at Lazard and on November 27 (2:30 pm ET) at Piper Jaffray. Webcasts available at...

November 5, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--TauRx Pharmaceuticals has selected BioClinica's Trident IWR/IVR and BioClinica Imaging Core Lab solutions for its upcoming Phase III clinical trials.

November 5, 2012

NORTH ANDOVER, Mass.--(BUSINESS WIRE)--MindChild Medical, Inc., and The University of Oxford Announces a Sponsored Research Agreement for the Development of Software for Fetal and Maternal Monitoring

November 5, 2012

SAINT PREX, Switzerland--(BUSINESS WIRE)--Marketing Authorisation Application for Ferring controlled release, removable misoprostol vaginal delivery system for induction of labour in women accepted for review by European health authorities.

November 5, 2012

CANTERBURY, England--(BUSINESS WIRE)--Ziarco has raised Series A funding from BVF and Pfizer to advance anti-inflammatory and anti-allergic agents. Ziarco has also licensed assets from Pfizer

November 5, 2012

CORK, Ireland & GHENT, Belgium--(BUSINESS WIRE)--The European Union has awarded €6m to a consortium - run by University College Cork and driven by two companies, Pronota and Metabolomic Diagnostics to develop a predictive test for pre-...

November 5, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: The shareholders of Global Health Partner AB (publ)(STO:GHP), corporate identity number 556757-1103, are hereby invited to attend the Extraordinary General Meeting to be held on Wednesday 28...

November 5, 2012

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Skuldtech, a genomic and pharmacogenomic company specialized in developing diagnostic tests, and AB Science (Paris:AB) (NYSE Euronext – FR0010557264 – AB), a pharmaceutical company...

November 5, 2012

OXFORD, England--(BUSINESS WIRE)--UK biotech PsiOxus received a £1.7 million ($2.7 million) grant award from the UK government-backed Biomedical Catalyst to fund a clinical trial for an oncolytic vaccine to fight ovarian cancer.

November 4, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Two-Year Data Show Long-Term Benefits
of Chronic Soliris® Therapy in Patients with aHUS

November 4, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--New Clinical Trial Data Show Substantial Improvement with Eculizumab (Soliris®) in Patients with STEC-HUS

November 3, 2012

TOKYO--(BUSINESS WIRE)--Otsuka announced the clinical trial results for tolvaptan, an investigational drug for the treatment of ADPKD, were presented for the first time at the ASN annual meeting and published online in NEJM.

November 3, 2012

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Skuldtech, a genomic and pharmacogenomic company specialized in developing diagnostic tests, and AB Science (NYSE Euronext – FR0010557264 – AB), a pharmaceutical company specialized in...

November 2, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Hagens Berman, an investor-rights law firm, is continuing to investigate Abiomed Inc. (NASDAQ:ABMD) regarding possible securities law violations following the company’s disclosure of a Department of Justice (DOJ)...

November 2, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) reported today that an equity award was made to a new employee subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan. The employee, Jyothi Tammineni, was...

November 2, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG), the developer of Biopump™, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own...

November 2, 2012

NASHVILLE, Tenn.--(BUSINESS WIRE)--Aegis Sciences Corporation has promoted Frank Moser to president. In this new role, he will lead strategic growth initiatives and direct the company’s day-to-day operations.

November 2, 2012

GENEVA & ARCHAMPS, France--(BUSINESS WIRE)--Genkyotex's NOX inhibitor GKT137831 has demonstrated excellent safety and tolerability in Phase I. Data presented at Kidney Week 2012, the annual meeting of the American Society of Nephrology.

November 2, 2012

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today that the Company’s Global Vice President of Research and Development, Chuck Jaggers, will be a speaker at the first annual Texas Medical...

November 2, 2012

SEATTLE--(BUSINESS WIRE)--The Allen Institute for Brain Science and Vulcan Real Estate announced today that they will partner in bringing the Institute’s headquarters to the heart of Seattle’s South Lake Union neighborhood. The decision follows...

November 2, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--ACP-501 receives orphan designation from EMA for the treatment of familial LCAT deficiency. This enzyme replacement therapy designation provides an accelerated approval pathway for ACP-501.

November 2, 2012

BOSTON--(BUSINESS WIRE)--Antonio R. Gargiulo, MD of the Center for Infertility and Reproductive Surgery at Brigham and Women’s Hospital completed a live surgery for the American Society of Reproductive Medicine (ASRM), treating a patient...

November 2, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at investor conferences during November 2012. On Wednesday,...

November 2, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) reported yesterday that the jury in the Enzo action entitled Enzo Biochem, Inc. et al. vs. Applera Corp. and Tropix Inc. in New Haven, CT Civil Action No. 3:04cv929 (JBA), has rendered its...

November 2, 2012

SEATTLE--(BUSINESS WIRE)--November 2, 2012 – Dendreon Corporation (Nasdaq: DNDN) today reported results for the quarter ended September 30, 2012. Net product revenue for the quarter was $78 million, compared to $61 million for the quarter ended...

November 2, 2012

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Aerie announces positive top-line results from its Phase 2a study evaluating AR-13324 for the treatment of glaucoma.

November 2, 2012

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that a large number of data presentations sponsored by the companies on ELIQUIS® (apixaban) and the treatment of...

November 2, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (STO:AERO-B): January – September 2012 Global Net sales grew by 72% to SEK 110.8m (64.4). Adjusted for currency fluctuations, net sales rose by 69% Year over Year (Y-o-Y) The worldwide...

November 2, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) is pleased to announce that today the National Institute of Health and Clinical Excellence (NICE) has decided to recommend YERVOY® (ipilimumab), which is approved in the...

November 2, 2012

PALO ALTO, Calif. & DEERFIELD, Ill.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq:AFFY) and Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) today announced the presentation of post-hoc sub-group analyses of the EMERALD Phase 3 studies that evaluated...